13-Employee SoCal Startup Bioniz Has A $400 Million Valuation Post author:Sam Post published:December 19, 2017 Post category:BioPharma Forbes recently interviewed Nazli Azimi, the CEO and co-founder of Bioniz Therapeutics. Source: BioSpace You Might Also Like No Doubt: This is the Top Gene-Sequencing Stock to Buy This Year April 20, 2017 AmerisourceBergen Pays $815M Cash for Drug Wholesaler H. D. Smith November 20, 2017 McKesson Reports Fiscal 2017 Fourth-Quarter And Full-Year Results May 18, 2017
